Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ribonucleosides. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116555378A reveals a novel enzymatic method for ATP production reducing costs and ensuring stable supply chains for pharmaceutical intermediates globally.